Package 42708-034-30

Brand: lisinopril and hydrochlorothiazide

Generic: lisinopril and hydrochlorothiazide
NDC Package Sample

Package Facts

Identity

Package NDC 42708-034-30
Digits Only 4270803430
Product NDC 42708-034
Description

30 TABLET in 1 BOTTLE, PLASTIC (42708-034-30)

Marketing

Marketing Status
Marketed Since 2018-03-29
Brand lisinopril and hydrochlorothiazide
Generic lisinopril and hydrochlorothiazide
Sample Package Yes

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45b3f57a-8923-a353-e063-6294a90a0271", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197885"], "spl_set_id": ["ff7b2d81-9006-465d-9095-1bd8696a12a6"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["QPharma Inc"]}, "finished": true, "packaging": [{"sample": true, "description": "30 TABLET in 1 BOTTLE, PLASTIC (42708-034-30)", "package_ndc": "42708-034-30", "marketing_start_date": "20180329"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "42708-034_45b3f57a-8923-a353-e063-6294a90a0271", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "42708-034", "generic_name": "Lisinopril and Hydrochlorothiazide", "labeler_name": "QPharma Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "10 mg/1"}], "application_number": "ANDA076194", "marketing_category": "ANDA", "marketing_start_date": "20020701", "listing_expiration_date": "20261231"}